| Literature DB >> 35203813 |
Takashi Azuma1, Masaru Usui2, Tetsuya Hayashi1,3.
Abstract
The inactivating effect of ozone (O3)-based advanced oxidation processes (AOPs) (O3/H2O2, O3/UV, and O3/UV/H2O2 systems) on antimicrobial-resistant bacteria (AMRB) and antimicrobial-susceptible bacteria (AMSB) in sewage treatment plant (STP) wastewater was investigated. The AMRB were grouped into six classes: carbapenem-resistant Enterobacteriaceae (CRE), extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae (ESBL-E), multidrug-resistant Acinetobacter (MDRA), multidrug-resistant Pseudomonas aeruginosa (MDRP), methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant Enterococcus (VRE); these classes constituted the World Health Organization (WHO) global priority list of AMRB. The results indicate that O3-based advanced wastewater treatment inactivated all AMRB and AMSB (>99.9%) after 10 min of treatment, and significant differences (p < 0.5) were not observed in the disinfection of AMRB and AMSB by each treatment. Altered taxonomic diversity of micro-organisms based on 16S rRNA gene sequencing via O3/UV and O3/UV/H2O2 treatment showed that advanced wastewater treatments not only inactivated AMRB but also removed antimicrobial resistance genes (AMRGs) in the wastewater. Consequently, this study recommends the use of advanced wastewater treatments for treating the STP effluent, reducing environmental pollution, and alleviating the potential hazard to human health caused by AMRB, AMSB, and infectious diseases. Overall, this study provides a new method for assessing environmental risks associated with the spread of AMRB and AMSB in aquatic environments, while keeping the water environment safe and maintaining human health.Entities:
Keywords: advanced oxidation process (AOPs); antimicrobial resistance (AMR); inactivation; ozonation; river environment; sewage treatment plant (STP)
Year: 2022 PMID: 35203813 PMCID: PMC8868322 DOI: 10.3390/antibiotics11020210
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Occurrence of AMRB and AMSB in sewage treatment plant (STP) influent, STP secondary effluent, and STP effluent.
| Bacteria | Bacteria Counts (CFU/mL) | ||
|---|---|---|---|
| STP Influent | STP Secondary | STP Effluent | |
| CRE | 317 | 201 | 1 |
| ESBL-E | 814 | 182 | 34 |
| MDRA | 323 | 19 | 2 |
| MDRP | 98 | N.D. | N.D. |
| MRSA | 58 | 7 | 6 |
| VRE | 200 | 3 | N.D. |
|
| 391 | 38 | 8 |
|
| 2528 | 836 | 219 |
|
| 30,000 | 115 | N.D. |
|
| 117 | N.D. | N.D. |
|
| 96 | 8 | 17 |
CRE: carbapenem-resistant Enterobacteriaceae, ESBL-E: extended-spectrum β-lactamase-producing Enterobacteriaceae, MDRA: multidrug-resistant Acinetobacter, MDRP: multidrug-resistant Pseudomonas aeruginosa, MRSA: methicillin-resistant Staphylococcus aureus, VRE: vancomycin-resistant Enterococcus, and N.D.: Not detected).
Figure 1Relative residual antimicrobial-resistant bacteria (AMRB) under O3-based AOP treatment (C0: initial bacterial counts; C: bacterial counts after treatment): (a) O3/H2O2, (b) O3/UV, (c) O3/UV/H2O2. (CRE: carbapenem-resistant Enterobacteriaceae, ESBL-E: extended-spectrum β-lactamase-producing Enterobacteriaceae, MDRA: multidrug-resistant Acinetobacter, MDRP: multidrug-resistant Pseudomonas aeruginosa, MRSA: methicillin-resistant Staphylococcus aureus, and VRE: vancomycin-resistant Enterococcus).
Figure 2Relative residual antimicrobial-susceptible bacteria (AMSB) under O3-based AOPs treatment (C0: initial bacterial counts, C: bacterial counts after treatment): (a) O3/H2O2, (b) O3/UV, (c) O3/UV/H2O2.
Reaction rate constants for each AMRB and AMSB during O3-based AOP treatment for STP wastewater. (* Reported values from the previous research [57].)
| Bacteria | Inactivation Rate (min−1) | |||
|---|---|---|---|---|
| O3/H2O2 | O3/UV | O3/UV/H2O2 | O3 * | |
| CRE | 2.239 | 5.668 | 7.054 | 1.978 |
| ESBL-E | 0.196 | 3.586 | 3.431 | 0.539 |
| MDRA | 0.596 | 0.785 | 9.576 | 0.311 |
| MDRP | 1.290 | 1.976 | 4.242 | 0.523 |
| MRSA | 0.368 | 1.386 | 2.773 | 0.274 |
| VRE | 1.817 | 5.748 | 6.398 | 2.508 |
|
| 1.649 | 4.187 | 10.225 | 0.426 |
|
| 1.165 | 3.496 | 5.776 | 0.725 |
|
| 2.902 | 9.479 | 4.056 | 2.515 |
|
| 1.610 | 9.716 | 6.870 | 0.295 |
|
| 0.230 | 5.278 | 3.892 | 0.129 |
Figure 3Taxonomic diversity of bacterial communities in O3-based AOP-treated wastewater samples.
Figure 4O3 consumption over time in STP wastewater in each treatment system.